Friday, 23 Aug 2019

You are here

RheumNow Podcast – Late Breaking Abstract Wrap-Up (6.21.19)

Dr. Jack Cush reviews the week’s news and wrap up from EULAR19.

  1. FORWARD, a National Databank study, looked at malignancies & infections in RA pts starting abatacept, other biologicsor DMARDs. No difference in cancer risks, but ABA had lower risk hospitalized infx (HR 0.37) & lower infusion/injx rxn than other biologics
  2. ethotrexate assoc. lymphoproliferative disorders (LPDs), is a rare disorder that resolves w/ MTX withdrawal (in 3-10mos). Most common path was diffuse large B-cell lymphoma and 45-77% had Epstein-Barr virus encoded RNA positivity.
  3. #EULAR2019 Emapalumab - a monoclonal Ab against IFNγ - was shown to be effective in 6 systemic JIA patients with macrophage activation syndrome. Rx led to rapid neutralization of IFNγ, normalization of CXCL9, & decreased T cell activation. OP0204
  4. A survey of 900 Danish rheumatic dz pts shows that 1 in 10 with pain have considered suicide in the last 4 weeks and that this was strongly influenced by poor quality sleep. #EULAR2019 OP0347
  5. No Difference Among Biologics in Arthroplasty Infectious Risk
  6. Allopurinol Fails to Curtail Hypertension 
  7. Is Methotrexate Necessary with Tofacitinib  
  8. EULAR 2019- Day 4 Report
    1. SPIRIT-H2H trial in PsA: LB005 
    2. Early AMPLE study LB008 
    3. Vagal Nerve Stimulation in RA: LB009



The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

RheumNow Podcast – Upadacitinib FDA Approved for RA (8.23.19)

Dr. Jack Cush reports on the news and journal reports from the past week on, including: how your genetics may shape your microbiome; GERD as a risk factor for TMJ?; how can MDA-5+ dermatomyositis be any worse; new drug happenings;; and more.

RheumNow Podcast – Antibiotics Increase RA Risk (8.16.19)

Dr. Jack Cush reports the news and important journal articles from the past week on

RheumNow Podcast – Tricked Up Lupus Criteria (8.9.19)

Dr. Jack Cush reviews the news and journal reports from the past week on, including new SLE criteria, ULT in gout and MSU reductions, IVIG in ANCA vasculitis and non-TNF biologics outperform the TNF inhibitors.

EULAR Recommendations on Large Vessel Vasculitis

Th European League Against Rheumatism (EULAR) recommendations for the management of large vessel vasculitis (LVV) was originally published in 2009. Since then there have been new randomised clinical trials and cohort analyses leading to an update the original recommendations.

RheumNow Podcast – More Than a Spot of Tea (8.2.19)

Dr. Jack Cush reviews the journal articles and news reports from the past week on MMP-7 and Myositis-ILD; Post-surgical gout attacks; CV events and testosterone; and a Boxed warning for tofacitinib.